"Virustatic coating offers 96 protection against airborne viruses."
Inventor, Paul Hope
Virustatic Shield is the response of leading Manchester scientists to the problem that face masks won’t stop the coronavirus. It is a fresh weapon in the fight to control the pandemic—and now it is available to the general public.
The innovative antiviral fabric coating applied to a light, easy-to-wear snood traps 96% of airborne viruses. It is the result of 10 years research by Manchester biochemists. The team behind it are working round the clock to bring it to full production in response to the global outbreak of COVID-19.
Unlike ordinary masks, Virustatic Shield can be worn comfortably for hours at a time, it is reusable, washable and harmless to touch after being exposed to germs.
The coating gives real virus stopping power to the thinnest material. It acts as a barrier to viruses carried in aerosols invisible to the human eye. The coating’s cationic properties attract, trap and kill viruses in airborne droplets 15 times smaller than a human hair.
Tests show it is effective against a range of pathogens including coronavirus, flu, SARS, MERS and the common cold. And Virustatic Shield’s super-fine material is 100% breathable. This means it is safe to be worn by those suffering from extreme respiratory problems.
Research and development of the Virustatic Shield was a collaboration between world-leading scientists at Manchester University and across the UK.
It is particularly useful for those who believe they may have the coronavirus and do not want to infect family, friends or others they are in contact with.
The World Health Organisation advises that healthy people only need to wear protective masks when taking care of a person with suspected 2019-nCoV infection, or if coughing and sneezing. And Virustatic Shield is only effective in controlling the spread of germs when used alongside a strict personal hygiene routine, as explained by health officials.
Inventor Paul Hope, from Marple, says the research found that material treated with the harmless Virustatic coating offers “96% protection against airborne viruses”.
He adds: “I’m concerned that the biggest provider of viruses, the people you are treating, can’t wear existing masks. Issues with breathability mean you can’t put a mask on them. If they could, that would reduce the virus within the hospital environment.”
His Virustatic Shield has been designed to mould to the wearers face, making it suitable for men and women, young and old. While its single layer of cloth offers unrivalled virus protection.
Paul explains: “Our snood mask moulds to your face. And it’s all the way round…not just around your nose and mouth. It fits everyone. One problem with conventional masks is how do you fit test them? If men wear them with a bit of a beard, or children wear them, they don’t fit. There are so many different configurations. “
Manchester University coined the term “germ trap” to describe the antiviral properties of the Virustatic protein coating.
Prof Sabine Flitsch, from the Manchester Institute of Biotechnology, says Virustatic technology “helps prevent the spread of virus.”
She adds: “The surface of the material is very adhesive to viruses and the material itself can inactivate the virus once bound.”
The new technology means the medical-grade protection of Virustatic Shield can be offered at high street prices. Virustatic Shield is available to buy direct from the website virustaticshield.com (RRP £20).
To protect consumers against ineffective copies, each Virustatic Shield will be fitted with an anti-fake security label. Special heat-activated ink, invisible UV features and an encrypted QR code, linked to a unique serial number verifies the authenticity of each Virustatic Shield.